Worldwide
We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.
Leading the way to advance science in inflammatory and autoimmune diseases.
We are advancing innovation to combat infectious diseases like HBV, influenza and MDR.
We focus on advances for neurodegenerative, psychiatric and neurodevelopmental disorders.
We focus on first- and best-in-class therapeutics in molecular targeted therapies and cancer immunotherapy.
We are focusing on saving people’s eyesight from the leading causes of vision loss through pioneering therapies and cutting- edge research.
We focus on therapeutic modalities and enabling technologies.
Roche is committed to making a contribution to areas of huge unmet need and societal burden through transformative science like in cardiovascular and metabolic diseases
New biomarkers that address significant unmet medical needs.
Modular instrument solutions with a wide range of assays for emergency labs or health clinics up to large hospitals and commercial networks.
POC instruments and IT solutions delivering quick, accurate and reliable results for critical- and primary-care clinicians and for patient self testing.
Diabetes management by an integrated portfolio of glucose monitoring systems, lancing devices, insulin delivery systems and digital solutions.
Advanced solutions in oncology, genetics, microbiology, virology and women’s health for commercial and hospital labs plus innovative screening products for blood banks.
Standardising and optimising processes in pathology, haematology or other specialty labs.
Innovative IT solutions to improve in vitro testing efficiency and support decision making.
Connect with our partnering experts to start the conversation.
At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.